Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors - the randomized phase II Motivate AYA - MAYA trial.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 10 3 2021
medline: 24 7 2021
entrez: 9 3 2021
Statut: ppublish

Résumé

To explore whether a structured counselling-based intervention increases vigorous physical activity behaviour of adolescent and young adult cancer survivors. Randomized controlled phase II trial. University Cancer Center Hamburg, Germany. Eighty-nine participants (mean age 24.1 ± 6.3) were randomized to control ( The intervention group was consulted about physical activity behaviour via interview (week 0), and telephone counselling (weeks 1, 3 and 12). The control group only received general physical activity guidelines for cancer survivors (week 0). The primary outcome was the rate of participants with ⩾9 metabolic equivalent (MET)-hours per week of vigorous activity post-intervention, measured with the International Physical Activity Questionnaire. Secondary outcomes included assessing physical activity behaviour (e.g. amount and type of physical activity) and quality of life. Assessments were completed in weeks 0 (baseline), 12 (post-intervention) and 52 (follow-up). Sixty-nine participants completed the post-intervention- and 47 the follow-up-assessment. The rate of participants performing vigorous physical activity increased from baseline to post-intervention for both without differing significantly ( A structured counselling-based physical activity intervention did not significantly impact the level of vigorous physical activity behaviour in adolescent and young adult cancer survivors.

Identifiants

pubmed: 33685232
doi: 10.1177/0269215521997974
pmc: PMC8273535
doi:

Types de publication

Clinical Trial, Phase II Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1164-1174

Références

J Clin Oncol. 2016 May 10;34(14):1626-33
pubmed: 26951318
J Pediatr Hematol Oncol. 2008 Apr;30(4):272-80
pubmed: 18391695
Psychooncology. 2014 Oct;23(10):1196-9
pubmed: 24639118
J Cancer Surviv. 2014 Sep;8(3):460-71
pubmed: 24719269
Health Educ Res. 2002 Aug;17(4):451-60
pubmed: 12197590
Pediatr Blood Cancer. 2017 Feb;64(2):387-394
pubmed: 27615711
Crit Rev Oncol Hematol. 2017 Oct;118:27-41
pubmed: 28917267
Prog Cardiovasc Dis. 2017 Mar - Apr;59(5):455-462
pubmed: 27640186
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Support Care Cancer. 2009 Aug;17(8):1041-8
pubmed: 19015892
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
J Clin Oncol. 2017 Jul 10;35(20):2288-2298
pubmed: 28530852
Int J Sports Med. 2016 Nov;37(12):979-985
pubmed: 27557405
Addict Behav. 1982;7(2):133-42
pubmed: 7102444
Pediatr Blood Cancer. 2016 Sep;63(9):1629-35
pubmed: 27198652
Support Care Cancer. 2015 Feb;23(2):501-10
pubmed: 25294658
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Adolesc Young Adult Oncol. 2016 Jun;5(2):91-105
pubmed: 26871647
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Adolesc Young Adult Oncol. 2016 Jun;5(2):78-90
pubmed: 26812458
JAMA Oncol. 2018 Oct 1;4(10):1352-1358
pubmed: 29862412
J Cancer Surviv. 2013 Sep;7(3):355-68
pubmed: 23532799
Cancer Treat Rev. 2017 Apr;55:57-70
pubmed: 28340450
PLoS One. 2018 Aug 9;13(8):e0201449
pubmed: 30092052
Cancer. 2016 Sep 1;122(17):2747-56
pubmed: 27258389
J Clin Oncol. 2014 Nov 10;32(32):3643-50
pubmed: 25311213
J Adolesc Young Adult Oncol. 2011 Dec;1(4):188-194
pubmed: 23610737
BMC Cancer. 2020 Jan 6;20(1):16
pubmed: 31906955
Behav Modif. 2002 Apr;26(2):223-73
pubmed: 11961914
Front Psychol. 2018 Dec 17;9:2402
pubmed: 30618907
J Adolesc Young Adult Oncol. 2019 Oct;8(5):512-524
pubmed: 31090475

Auteurs

Jannike Salchow (J)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Barbara Koch (B)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Julia Mann (J)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Julia von Grundherr (J)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Simon Elmers (S)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Sarah Dwinger (S)

Department for Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Gabriele Escherich (G)

Department of Pediatric Hematology and Oncology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Eik Vettorazzi (E)

Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Rüdiger Reer (R)

Institute of Human Movement Science, Faculty of Psychology and Human Movement, University of Hamburg, Hamburg, Germany.

Marianne Sinn (M)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Freerk Baumann (F)

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University Hospital of Cologne, Cologne, Nordrhein-Westfalen, Germany.

Carsten Bokemeyer (C)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Alexander Stein (A)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Wiebke Jensen (W)

Department of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH